Serotonin

Preface.- 1. Different Organization of Human Monoamine Oxidase (MAO) A and B Promoters.- 2. Molecular Biology of Serotonin Uptake Sites.- 3. Molecular Biology of 5-HT1 Receptors.- 4. 5-HT-Receptor Agonists Block C-fos-LI within Trigeminal Nucleus Caudalis in Response to Noxious Meningeal Stimulation.- 5. A Reappraisal of 5-HT Receptor Classification.- 6. Classification of Agents Used in Serotonin Research.- 7. Electrophysiology of Central Serotonin Neurotransmission.- 8. Immunohistochemical Visualization of 5-HT1A Receptors in the Rat Brain.- 9. In Vitro Functional Correlates of 5-HT1-Like Receptors.- 10. 5-HT1D Receptor Subtypes.- 11. 5-HT3 Receptors.- 12. 5-HT4 Receptor: Current Status.- 13. Serotonergic Receptors: From Ligands to Sequence.- 14. Possible Mechanisms of Action of Drugs Effective Against Acute Migraine Attacks.- 15. SB 203186, A Potent 5-HT4 Antagonist for Cardiac 5-HT4 Receptors.- 16. Role of the Lateral Tegmental Field in the Sympatholytic Action of 5HT1A Agonists.- 17. Urapidil: The Role of 5-HT1A and Ó-Adrenergic Receptors in Blood Pressure Reduction.- 18. Clinical Aspects of Antiemesis: Role of the 5-HT3 Antagonists.- 19. The Antiemetic Properties of 5-HT3 Receptor Antagonists.- 20. Mechanisms of the Emetic Response to Chemotherapy and of the Antiemetic Action of 5-HT3 Receptor Antagonists: Clinical Studies.- 21. Serotonin and Serotonergic Drugs in Emesis.- 22. Clinical Effects of 5-HT3 Antagonists in Treating Nausea and Vomiting.- 23. Inhibitors of Serotonin Uptake.- 24. Preclinical Evidence for the Role of Serotonin Receptors in Anxiety.- 25. The Effects of Tryptophan Depletion in Depression.- 26. Anxiolytic Effects of Drugs Acting on 5-HT Receptor Subtypes.- 27. Obsessive Compulsive Disorders: A Neurobiological Hypothesis.- 28. Role of theSerotonergic System in Pituitary Hormone Secretion: The Pharmacologic Challenge Paradigm in Man.- 29. Serotonin in Anxiety and Related Disorders.- 30. Alcoholic Violent Offenders: Behavioral, Endocrine, Diurnal Rhythm, and Genetic Correlates of Low CSF 5-HIAA Concentrations.- 31. Modulation of Dopaminergic Neurotransmission by 5-HT2 Antagonism.- 32. Combined Serotonin 5-HT2 and Dopamine DA2 Antagonist Treatments in Chronic Schizophrenia.- 33. Is Serotonin Involved in the Pathogenesis of Schizophrenia.- 34. Serotonin Antagonists as Antipsychotics.- 35. Pharmacological Analysis of 5-HT Receptors in Human Small Coronary Arteries.- 36. Platelets, Platelet Mediators, and Unstable Coronary Artery Disease Syndromes.- 37. Abnormal Coronary Vasoconstrictor Responses to Serotonin in Patients with Ischemic Heart Disease.- 38. 5-HT and the Immune System.- 39. The Stimulatory Effects of d-Fenfluramine (d-FEN) on Blood and Splenic Immune Functions in the Fischer 344 Rat are Age and Sex Dependent.- 40. Serotonergic Regulation of Natural Killer Cells: A Minireview.- 41. Interactions between Serotonin and the Immune System: An Overview.- 42. The Role of Serotonin in the Cellular Physiological Effects of Cocaine.- 43. Serotonin Mechanisms in Ethanol Abuse.- 44. Serotonin Regulation of Alcohol Drinking.- 45. Hypothalamic Serotonin in Relation to Appetite for Macronutrients andEating Disorders.- 46. Serotonergic Pharmacology of Appetite.- 47. Serotonin (5-HT)IA Receptor Agonists and Neuroprotection.- 48. New Antidementia Molecules which Selectively Influence Serotonin Receptor Subtypes.- 49. Pharmacological Modulation of the Serotonergic System: An Overview of the Effects on Normal and Pathological Sleep.